ClinConnect ClinConnect Logo
Search / Trial NCT06842901

Feasibility Study on PoRi Device

Launched by YALE UNIVERSITY · Feb 18, 2025

Trial Information

Current as of May 29, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new device designed to help people with hand spasticity, which means their hand muscles are tight and hard to control. The device gently moves the hands of patients to help reduce this tightness. The study will take place at Yale New Haven Hospital, where participants will use the device during a 20-minute session to see how it affects their hand muscle tone before and after treatment.

To participate in this trial, individuals should be between 65 and 74 years old and have difficulty moving their fingers due to conditions like paralysis or motor function issues, with a specific score on a muscle tightness scale. Unfortunately, younger individuals under 18, and those who cannot stretch their fingers and wrists properly, will not be eligible. This study is not currently recruiting participants, but it aims to understand how effective this device can be for improving hand movement in people with spasticity.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Modified Ashworth Scale (MAS) score of at least 1
  • Participants with paralysis or motor function problems of the fingers of one or both hands.
  • Exclusion Criteria:
  • Minors (below age 18)
  • Vulnerable populations
  • Inability of fingers and wrist to stretch to neutral during passive range of motion

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

New Haven, Connecticut, United States

New Haven, Connecticut, United States

Patients applied

0 patients applied

Trial Officials

Necolle Morgado-Vega

Principal Investigator

Yale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported